// App-Quantinova.ai

: Adherence to home spirometry among patients with IPF: results from the INMARK trial

Researchers

Presenter

  • Imre Noth

Principal Investigators

  • Toby M Maher

  • Kerri A Johannson

  • Nazia Chaudhuri

  • Stphane Jouneau

  • Andreas Michael

  • Klaus B Rohr

  • Manuel Quaresma

  • Susanne Stowasser

  • Vincent Cottin

Medical Centers

  • Division of Pulmonary & Critical Care Medicine, University of Virginia, Charlottesville, VA, United States,

  • National Heart and Lung Institute, Imperial College London, UK and National Institute for Health Research Clinical Research Facility, Royal Brompton Hospital, London, UK, London, United Kingdom

  • Dept of Community Health Sciences, Univ of Calgary, Calgary, Canada

  • North West Interstitial Lung Disease Unit, Manchester University Foundation Trust, Wythenshawe, Manchester, United Kingdom

  • Hôpital Pontchaillou - CHU de Rennes, IRSET UMR 1085, Université de Rennes 1, Rennes, France,

  • Syneos Health, Farnborough, United Kingdom

  • Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany,

  • National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1, Lyon, France,

Locations

  • United States

  • United Kingdom

  • Canada

  • France

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Nintedanib

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Open Label

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved